Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Prospective Study (Phase 2)

NCT03753724 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT03753724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03753724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Prospective Study (Phase 2)
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Completed
Start date
August 29, 2018
Completion date
March 31, 2022
Enrollment
1,293 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, pulmonary nodule, multiple, pulmonary nodule, solitary